Spinal cord stimulation improves motor function and gait in spastic paraplegia type 4 (SPG4): Clinical and neurophysiological evaluation

Hereditary spastic paraplegia is a heterogeneous group of genetic disorders characterized by degeneration of the corticospinal tracts, coursing with progressive weakness and spasticity of the lower limbs. To date, there are no effective treatments for progressive deficits or disease-modifying therap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parkinsonism & related disorders 2021-02, Vol.83, p.1-5
Hauptverfasser: Pinto de Souza, Carolina, Coelho, Daniel Boari, Campos, Débora da Silva Fragoso, dos Santos Ghilardi, Maria Gabriela, de Oliveira Vicente, Edrin Claro, González-Salazar, Carelis, Junior, Marcondes Cavalcante França, Barsottini, Orlando Graziani Povoas, Pedroso, José Luiz, Fonoff, Erich Talamoni
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hereditary spastic paraplegia is a heterogeneous group of genetic disorders characterized by degeneration of the corticospinal tracts, coursing with progressive weakness and spasticity of the lower limbs. To date, there are no effective treatments for progressive deficits or disease-modifying therapy for those patients. We report encouraging results for spastic paraparesis after spinal cord stimulation. A 51-year-old woman suffering from progressive weakness and spasticity in lower limbs related to hereditary spastic paraplegia type 4 underwent spinal cord stimulation (SCS) and experienced also significant improvement in motor function. Maximum ballistic voluntary isometric contraction test, continuous passive motion test and gait analysis using a motion-capture system were performed in ON and OFF SCS conditions. Neurophysiologic assessment consisted of obtaining motor evoked potentials in both conditions. Presurgical Spastic Paraplegia Rating Scale (SPRS) score was 26. One month after effective SCS was initiated, SPRS went down to 15. At 12 months follow up, she experienced substantial improvement in motor function and in gait performance, with SPRS scores 23 (OFF) and down to 20 (ON). There was an increased isometric muscle strength (knee extension, OFF: 41 N m; ON: 71 N m), lower knee extension and flexion torque values in continuous passive motion test (decrease in spastic tone) and improvement in gait (for example, step length increase). Despite being a case study, our findings suggest innovative lines of research for the treatment of spastic paraplegia. •There aren't effective treatments for progressive deficits at SPG4.•In a case report, we report encouraging results for SPG4 after SCS.•The patient had 42% and 23% improvement in SPRS at 1 and 12 months after SCS, respectively.•SCS improve isometric muscle strength and gait and decrease spasticity.
ISSN:1353-8020
1873-5126
DOI:10.1016/j.parkreldis.2020.12.008